Impact of soluble BCMA and non–T-cell factors on refractoriness to BCMA-targeting T-cell engagers in multiple myeloma
Most Cited Paper
in Monoclonal and Polyclonal Antibodies Research
18 Months Post-Publication
Class of 2026
“Impact of soluble BCMA and non–T-cell factors on refractoriness to BCMA-targeting T-cell engagers in multiple myeloma”
A research intelligence initiative by Pepkio
pri.pepkio.com/top-papers/monoclonal-and-polyclonal-antibodies-research/2026/
Topics
soluble BCMA · BCMA-targeting T-cell engagers · teclistamab · multiple myeloma · CAR T-cell therapy · primary refractoriness · BCMA expression · tumor burden · GPRC5D · gamma secretase inhibitors · whole-genome sequencing · in vitro cytotoxicity assay · TCE dose intensity · soluble BCMA · adoptive T-cell therapy · Predictive biomarker · correlative patient analysis · high-risk disease features · anti-BCMA therapy resistance · baseline sBCMA threshold
Share
Cite this ranking
Pepkio Research Index (PRI). Topics and Trends in Most Cited Monoclonal and Polyclonal Antibodies Research Papers, Class of 2026. https://pri.pepkio.com/top-papers/monoclonal-and-polyclonal-antibodies-research/2026. Accessed 2026-07-15. Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459